Everything about LE 300
Risdiplam is the only real orally administered drug authorised with the procedure of SMA. It had been FDA accepted in 2020 for use in people two months of age and more mature, and it functions being an SMN2 gene splicing modifier resulting in greater levels of SMN protein. Oral administration is a big benefit of this drug since it can impact system